Baker Bros. Advisors LP Axsome Therapeutics, Inc. Transaction History

Baker Bros. Advisors LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$21.74 - $46.75 $13.3 Million - $28.6 Million	-610,970 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $2.21 Million - $3.12 Million	71,913 Added 13.34%	610,970 $23.1 Million
Q2 2021 Aug 16, 2021	SELL	$50.63 - $73.5 $4.52 Million - $6.57 Million	-89,357 Reduced 14.22%	539,057 $36.4 Million
Q1 2021 May 17, 2021	SELL	$55.91 - $81.44 $8.41 Million - $12.3 Million	-150,420 Reduced 19.31%	628,414 $35.6 Million
Q4 2020 Feb 16, 2021	SELL	$66.31 - $86.52 $12 Million - $15.7 Million	-180,923 Reduced 18.85%	778,834 $63.5 Million
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $3.42 Million - $4.29 Million	-50,000 Reduced 4.95%	959,757 $68.4 Million
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $5.98 Million - $11.8 Million	120,000 Added 13.49%	1,009,757 $83.1 Million
Q1 2020 May 15, 2020	BUY	$41.2 - $101.31 $2.47 Million - $6.08 Million	60,000 Added 7.23%	889,757 $52.3 Million
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $960,340 - $6.11 Million	57,471 Added 7.44%	829,757 $85.8 Million
Q2 2019 Aug 14, 2019	SELL	$13.46 - $25.75 $5.76 Million - $11 Million	-427,714 Reduced 35.64%	772,286 $19.9 Million
Q1 2019 May 15, 2019	BUY	$2.63 - $16.34 $3.16 Million - $19.6 Million	1,200,000 New	1,200,000 $17.1 Million

288

40.4M

365K

428K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.84B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.